Home
Externa competence AB

Externa competence AB Market Share Analysis for May 2026

Externa har koll på regelverken. Med hjälp av vår kunskap, våra utbildningar och vår utrustning klarar du kraven på arbetsplatsen.

Industry: N/A

Domainexterna.se

Year Founded2016

Employees51 - 200

Annual Revenue--

Externa competence AB

Externa competence AB (including company regionals)

externa.se

See more website traffic and engagement information

Total visits to Externa competence AB's top domains

Understand Externa competence AB market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

externa.se312

See more with Sales Intelligence

Avg. visit duration in Externa competence AB's top domains

Analyze Externa competence AB engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

externa.se--

See more with Sales Intelligence

Avg. pageviews on Externa competence AB's top domains

See how Externa competence AB keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

externa.se1.00

See more with Sales Intelligence

Externa competence AB top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Externa competence AB

These are the website technologies, by industry, used by Externa competence AB top domains

Widget (5)

Twemoji

Content Management System (3)

WordPress

Conversion & Analytics (3)

Google Analytics

Mobile (2)

Meta Viewport

More Technologies

9

See all

News & Signals from Externa competence AB

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsExterna Competence AB is developing transformative therapies.Melbourne-based biotech startup exteRNA has raised $11 million in seed funding as it progresses plans to develop transformative therapies that target a unique aspect of RNA processing to fight cancers that are difficult to treat.